$0.23
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company is headquartered in Los Gatos, California and currently employs 26 full-time employees. The company went IPO on 2022-04-27. The firm has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.
Country

US

CEO

Mr. Steven Foster

IPO date

2022

Employees

26

ISIN

US88066N3035

Key stats

Open

$0.23

Volume

700.72K

Market cap

$4.00M

Prev. close

$0.23

Impl / hst vl

-

Open interest

$0.00

$0.23

Day’s Range

$0.24

$0.22

52W Range

$1.03

Valuation

66
Valuation score
Undervalued
P/E
-
P/S
0.87
P/B
2.11
Current ratio
1.03
Debt / Equity
-0.59
ROE
-269.24%
Gross margin
68.53%
Income growth
22.74%
FCF growth
24.83

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$2.68
The top 4 analysts forecasts that 12-month price may increase by 1,064.13%, with a low of $2.27 and a high of $3.15
$2.27
Low
$2.68
Avg
$3.15
High
Current price

Earnings

Q1 ‘26 revenue
$1.38M
Q1 ‘26 net income
-$3.48M
Revenue
Net income
Previous EPS
-$0.31
Estimate EPS
-$0.24
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply